Manganese is one of the most underappreciated essential trace minerals in human nutrition. Required in only tiny amounts — the adequate intake for adults is 1.8-2.3 mg per day — manganese nonetheless plays indispensable roles in metabolism, antioxidant defense, bone formation, wound healing, and brain function. It is a cofactor or component of enzymes involved in some of the most fundamental biochemical processes in the human body, yet it receives a fraction of the public attention given to iron, zinc, or calcium.
Understanding manganese — its biochemistry, dietary sources, deficiency states, toxicity risks, and emerging research — is understanding a mineral that sits quietly at the center of human metabolism.
Biochemistry: what manganese does in the body
Manganese functions primarily as an enzyme cofactor or activator — participating in dozens of enzymatic reactions across multiple metabolic pathways:
Manganese superoxide dismutase (MnSOD / SOD2)
MnSOD is perhaps the most critical manganese-dependent enzyme: located in the mitochondrial matrix, MnSOD catalyzes the dismutation of superoxide radical (O₂•⁻) to hydrogen peroxide (H₂O₂) and oxygen. This reaction is the first and most important step in mitochondrial antioxidant defense — without MnSOD, superoxide radicals would rapidly damage mitochondrial DNA, proteins, and lipids, leading to mitochondrial dysfunction and cell death (Fridovich, 1995, Annual Review of Biochemistry).
MnSOD knockout mice die within days of birth from severe oxidative damage — demonstrating the absolute essentiality of this enzyme. In humans, MnSOD polymorphisms (particularly the Ala16Val variant) are associated with altered cancer risk, cardiovascular disease, and diabetic complications (Sutton et al., 2003, Pharmacogenetics).
Arginase
Arginase — a manganese-containing metalloenzyme — catalyzes the hydrolysis of arginine to ornithine and urea, the final step of the urea cycle. Without arginase, the body cannot excrete nitrogen waste as urea — a function essential for protein metabolism and nitrogen homeostasis. Arginase also regulates nitric oxide production (by competing with nitric oxide synthase for the shared substrate arginine) — connecting manganese to vascular function, immune regulation, and neurotransmission (Caldwell et al., 2015, Trends in Pharmacological Sciences).
Pyruvate carboxylase
Pyruvate carboxylase — a manganese-dependent enzyme in the mitochondrial matrix — catalyzes the carboxylation of pyruvate to oxaloacetate, a critical anaplerotic reaction that replenishes the TCA cycle and provides substrate for gluconeogenesis. This enzyme connects manganese to energy metabolism, glucose homeostasis, and lipogenesis (Jitrapakdee et al., 2008, Biochemical Journal).
Glycosyltransferases
Manganese-dependent glycosyltransferases are essential for the synthesis of glycosaminoglycans (GAGs) — the structural components of cartilage, bone, and connective tissue: chondroitin sulfate, keratan sulfate, and other GAGs require manganese-activated glycosyltransferases for their synthesis; proteoglycan production in cartilage is manganese-dependent — connecting manganese to joint health and osteoarthritis (Keen et al., 1999, Experimental Biology and Medicine).
Glutamine synthetase
Glutamine synthetase — a manganese-dependent enzyme primarily expressed in astrocytes (brain glial cells) — converts glutamate (an excitatory neurotransmitter) to glutamine. This reaction is critical for: recycling the neurotransmitter glutamate, preventing excitotoxicity (excessive glutamate signaling that damages neurons), and ammonia detoxification in the brain (Suárez et al., 2002, Neurochemistry International).
Manganese absorption and homeostasis
Manganese homeostasis is tightly regulated — reflecting the metal's dual nature as both essential nutrient and potential neurotoxin:
Absorption
Dietary manganese is absorbed primarily in the small intestine — but absorption efficiency is low (approximately 3-5% of dietary intake is absorbed). Absorption is regulated by: iron status (iron and manganese share the divalent metal transporter 1 — DMT1 — and iron deficiency increases manganese absorption, potentially increasing toxicity risk); dietary factors (phytates, fiber, and calcium reduce manganese absorption; vitamin C may enhance it); and body manganese status (homeostatic regulation adjusts absorption based on need) (Aschner et al., 2007, Molecular Aspects of Medicine).
Distribution
Absorbed manganese is transported to the liver via the portal vein, where it is partially extracted by hepatocytes and the remainder enters systemic circulation — primarily bound to transferrin (Tf) and α2-macroglobulin. Manganese concentrates in: the liver (the primary organ of manganese metabolism and excretion), bone (contains approximately 25-40% of total body manganese), the brain (particularly the basal ganglia — globus pallidus, striatum, and substantia nigra), and the pancreas (where manganese is concentrated in islet cells) (Aschner & Aschner, 2005, Molecular Aspects of Medicine).
Excretion
Manganese is excreted primarily through biliary secretion into the feces — with minimal urinary excretion. Hepatobiliary excretion is the body's primary mechanism for preventing manganese accumulation and toxicity. Liver disease — which impairs biliary excretion — is a risk factor for manganese toxicity (Roth, 2006, Biochemical Pharmacology).
Manganese deficiency
Clinical manganese deficiency is rare in humans (the dietary supply from whole grains, nuts, legumes, and tea is generally adequate), but experimental manganese depletion in humans has produced: impaired glucose tolerance (reduced insulin secretion and/or action), altered lipid metabolism (increased LDL cholesterol), skin rash and dermatitis, decreased serum cholesterol, impaired cartilage and bone formation, and reproductive abnormalities (in animal models — impaired testicular function, ovulatory dysfunction, and fetal skeletal malformations) (Keen et al., 1999, Experimental Biology and Medicine).
Populations at risk for deficiency
Iron-replete individuals (high iron status may suppress manganese absorption through DMT1 competition); individuals on highly refined diets (processing removes manganese from grains); individuals with chronic malabsorptive conditions (celiac disease, IBD, short bowel syndrome); and premature infants (born with low manganese stores and receiving parenteral nutrition without adequate manganese supplementation).
Manganese toxicity: manganism
While dietary manganese toxicity is extremely rare, occupational and environmental manganese overexposure produces a well-characterized neurotoxic syndrome called manganism:
Occupational exposure
Manganism was first described in 1837, among manganese ore miners — and occupational exposure remains the primary cause: mining and smelting of manganese ore, welding (manganese is a common component of welding rods and fumes — welders have significantly higher manganese exposure), dry-cell battery manufacturing, steel production (manganese is used as a deoxidizer and alloying element), and agricultural exposure to manganese-containing fungicides (maneb, mancozeb) (Lucchini et al., 2014, NeuroToxicology).
Clinical features
Manganism presents with a Parkinson-like syndrome — but with important clinical differences: early symptoms include psychiatric disturbances (compulsive behavior, emotional lability, hallucinations — historically called "manganese madness" or "locura manganica"); progressive motor symptoms include bradykinesia (slowness), rigidity, postural instability, and a characteristic "cock walk" (walking on the toes with the trunk flexed forward); unlike Parkinson's disease, manganism primarily affects the globus pallidus and striatum (rather than the substantia nigra), produces less resting tremor, and does not respond to levodopa therapy (Guilarte, 2013, Environmental Health Perspectives).
Neuroimaging
MRI is a key diagnostic tool: manganese is paramagnetic — accumulation in the basal ganglia produces characteristic hyperintense signals on T1-weighted MRI, particularly in the globus pallidus. This T1 hyperintensity is nearly pathognomonic for manganese accumulation and is used to monitor exposure in occupational settings (Criswell et al., 2012, Neurology).
Manganese and bone health
Manganese's role in bone metabolism is underappreciated: manganese-dependent glycosyltransferases synthesize the proteoglycans that form the organic matrix of bone; manganese activates alkaline phosphatase — an enzyme essential for bone mineralization; manganese deficiency in animal models produces severe skeletal abnormalities (shortened and thickened bones, joint deformities); and epidemiological studies have found associations between low manganese intake and decreased bone mineral density, particularly in postmenopausal women (Saltman & Strause, 1993, Journal of the American College of Nutrition).
Manganese and diabetes
Emerging research connects manganese to glucose metabolism: MnSOD polymorphisms are associated with type 2 diabetes risk — the Ala16Val variant (which reduces MnSOD activity) increases oxidative damage to pancreatic β-cells; manganese depletion impairs insulin secretion and glucose tolerance in experimental studies; diabetic patients have been found to have lower blood manganese levels than non-diabetic controls in several epidemiological studies; and manganese supplementation improved glucose tolerance in some animal models of diabetes (Li & Yang, 2018, Nutrients).
Manganese and brain function
Beyond manganism, manganese has important roles in normal brain function: glutamine synthetase (the manganese-dependent enzyme in astrocytes) is essential for neurotransmitter recycling and brain ammonia detoxification; manganese is required for the synthesis of neuroactive compounds and neurotransmitter metabolism; and MnSOD protects neurons from oxidative damage — mitochondrial oxidative stress is a central mechanism of neurodegeneration (Aschner et al., 2009, Advances in Neurobiology).
Dietary sources and recommendations
The richest dietary sources of manganese include: whole grains (brown rice, oats, wheat germ — a single serving often provides >50% of AI), nuts (pecans, almonds, hazelnuts), legumes (chickpeas, lentils, soybeans), tea (one of the richest dietary sources — a cup of black tea provides 0.4-1.3 mg manganese), pineapple (one of the few fruits rich in manganese), dark chocolate, and green leafy vegetables (spinach, kale) (Institute of Medicine, 2001, Dietary Reference Intakes).
The adequate intake (AI) is 2.3 mg/day for men and 1.8 mg/day for women — relatively easily achieved with a varied diet containing whole grains and plant foods. The tolerable upper intake level (UL) is 11 mg/day — above which the risk of neurological effects increases.
Manganese and the microbiome
Emerging research reveals that manganese availability in the gut affects microbial ecology: many gut bacteria require manganese for their manganese-dependent enzymes (MnSOD, manganese catalase); pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae) compete with host cells for manganese — the host immune system's strategy of restricting manganese availability ("nutritional immunity") represents a defense mechanism against infection; calprotectin — an antimicrobial protein released by neutrophils — sequesters both zinc and manganese, starving pathogens of these essential metals (Kehl-Fie & Skaar, 2010, Current Opinion in Chemical Biology).
Environmental manganese exposure
Beyond occupational settings, environmental manganese exposure is an emerging public health concern: drinking water contamination (manganese in well water — particularly in parts of Bangladesh, Canada, and the United States — has been associated with cognitive deficits in children); the gasoline additive methylcyclopentadienyl manganese tricarbonyl (MMT) — used as an antiknock agent in some countries — releases manganese into the atmosphere through vehicle exhaust; soil contamination near manganese mining and smelting operations; and infant formula (soy-based formulas contain significantly higher manganese than breast milk — prompting concerns about potential neurodevelopmental effects) (Bouchard et al., 2011, Environmental Health Perspectives).
Future research directions
Active areas of manganese research include: the role of SLC30A10 and SLC39A14 — recently identified manganese transporters — in manganese homeostasis and disease (mutations cause inherited manganese excess or deficiency syndromes); manganese and neuroimaging biomarkers for early detection of neurotoxicity before clinical symptoms appear; the interaction between manganese and iron metabolism — particularly relevant for populations with iron deficiency (who are at increased manganese absorption and potential toxicity risk); the therapeutic potential of manganese-based MRI contrast agents (manganese is a naturally paramagnetic T1 contrast agent — manganese-based contrast agents may offer advantages over gadolinium in certain imaging applications); and the role of manganese in cancer biology (MnSOD activity influences tumor growth, metastasis, and treatment sensitivity) (Chen et al., 2018, Free Radical Biology and Medicine).
Manganese is a mineral of contradictions — essential in trace amounts, toxic in excess, invisible in public health discussions, yet indispensable for the enzymes that defend our mitochondria, build our bones, detoxify our brains, and fuel our metabolism. Understanding it fully requires appreciating both its quiet essentiality and its dangerous potential — a balance that reflects the broader truth about trace minerals in human biology.
Manganese and reproduction
Manganese plays essential roles in reproductive biology: in males, manganese is concentrated in the testes and is required for normal sperm production and function — manganese deficiency in animal models produces testicular atrophy, impaired spermatogenesis, and reduced fertility; in females, manganese is involved in steroidogenesis (sex hormone synthesis), follicular development, and embryonic development — manganese-deficient female animals show impaired ovulation, reduced conception rates, and fetal skeletal malformations; and during pregnancy, manganese requirements increase — inadequate manganese during gestation is associated with impaired fetal bone development and growth restriction in animal models (Keen et al., 1999, Experimental Biology and Medicine).
Manganese and wound healing
Manganese participates in multiple wound healing pathways: MnSOD protects healing tissue from oxidative damage; manganese-dependent glycosyltransferases synthesize the glycosaminoglycans required for extracellular matrix assembly; arginase (manganese-dependent) converts arginine to ornithine — a precursor for both proline (used in collagen synthesis) and polyamines (required for cell proliferation); and prolidase — a manganese-dependent enzyme — recycles proline from degraded collagen, providing substrate for new collagen synthesis.
Manganese and the blood-brain barrier
Manganese has a unique relationship with the brain: unlike most metals, manganese readily crosses the blood-brain barrier — transported by multiple mechanisms including transferrin-receptor-mediated endocytosis, DMT1, and calcium channels. This ready access to the CNS underlies both manganese's essential roles in brain function (glutamine synthetase, MnSOD) and its neurotoxic potential when exposure is excessive. The brain's limited capacity to excrete manganese (compared to the liver's biliary excretion pathway) makes it particularly vulnerable to manganese accumulation (Yokel, 2009, Journal of Alzheimer's Disease).
Manganese analytical methods and biomarkers
Assessing manganese status is challenging: blood manganese levels are tightly homeostanically regulated and do not reliably reflect tissue stores or dietary adequacy; hair and nail manganese levels are affected by external contamination; MRI T1 signal intensity in the globus pallidus is the most sensitive biomarker for manganese overexposure — but is not suitable for assessing nutritional adequacy; and emerging biomarkers include erythrocyte MnSOD activity, which may reflect functional manganese status more accurately than plasma manganese concentration (Greger, 1998, Neurotoxicology).
Manganese exemplifies the paradox of trace mineral nutrition — too little impairs the enzymes that protect mitochondria, build bones, and detoxify the brain; too much damages the very brain it was meant to protect. Understanding this balance is understanding one of the most fundamental challenges of trace element biology.
Manganese and Parkinson's disease
The clinical overlap between manganism and Parkinson's disease has spurred research into manganese's role in idiopathic PD: while manganism primarily affects the globus pallidus (not the substantia nigra), chronic low-level manganese exposure may contribute to PD risk in susceptible individuals; welders — who have chronic manganese exposure — show increased rates of Parkinsonism in epidemiological studies, though the relationship to classic PD is debated; cellular studies show that manganese can synergize with other PD risk factors (α-synuclein aggregation, mitochondrial complex I inhibition) — potentially lowering the threshold for dopaminergic neuron death; and manganese-induced oxidative stress in the basal ganglia may activate neuroinflammatory cascades that propagate to the substantia nigra over time (Racette et al., 2012, Neurology).
Manganese in water: emerging public health concern
Water manganese contamination is an evolving environmental health issue: while the EPA secondary drinking water standard for manganese is 50 μg/L (based on aesthetic concerns — taste and staining), studies in children have found cognitive effects at manganese concentrations below this standard; Bouchard et al. (2011, Environmental Health Perspectives) found that children exposed to higher water manganese concentrations had lower IQ scores — with significant effects beginning at concentrations as low as 100 μg/L (only twice the aesthetic standard); and these findings have prompted calls for lowering the regulatory standard for manganese in drinking water — though this remains under debate.
Manganese is proof that trace minerals exist on a razor's edge between deficiency and toxicity — a mineral where understanding the dose-response relationship is not merely academic but has direct implications for public health, occupational safety, and clinical nutrition.
Manganese and epilepsy
Manganese has connections to seizure disorders: glutamine synthetase (manganese-dependent) converts the excitatory neurotransmitter glutamate to the non-neuroactive amino acid glutamine in astrocytes — this is the primary mechanism for terminating glutamatergic excitatory signaling; impaired glutamine synthetase activity (from manganese deficiency or enzyme dysfunction) leads to glutamate accumulation → excitotoxicity → seizure susceptibility; interestingly, manganese excess can also cause seizures — through direct neurotoxic effects on GABAergic neurons in the basal ganglia, reducing inhibitory neurotransmission; and this bidirectional relationship between manganese and seizures further illustrates the narrow therapeutic window of trace mineral biology.
Manganese measurement in clinical practice
The measurement of manganese status presents unique challenges: whole blood manganese (reference range approximately 4-14 μg/L) is the most commonly used clinical measure — but it reflects recent exposure more than long-term body stores; serum or plasma manganese levels are even less reliable — because manganese is primarily distributed within erythrocytes (with much lower concentrations in serum); bone manganese (measurable by neutron activation analysis) may better reflect long-term stores — but this technique is not clinically available; and MRI pallidal index (the ratio of T1 signal intensity in the globus pallidus to that in subcortical white matter) is the most sensitive indicator of manganese accumulation in the brain — used primarily in occupational medicine surveillance.